Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial

Apfelbaum, 2003, Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged, Anesth Analg, 97, 534, 10.1213/01.ANE.0000068822.10113.9E Sinatra, 2002, Pain management after major orthopaedic surgery: Current strategies and new concepts, J Am Acad Orthop Surg, 10, 117, 10.5435/00124635-200203000-00007 Austrup, 1999, Analgesic agents for the postoperative period. Opioids, Surg Clin North Am, 79, 253, 10.1016/S0039-6109(05)70382-0 Brown, 2004, Strategies for postoperative pain management, Best Pract Res Clin Anaesthesiol, 18, 703, 10.1016/j.bpa.2004.05.004 Jain, 1997, Postoperative pain management, Chest Surg Clin N Am, 7, 773 American Society of Anesthesiologists Task Force on Acute Pain Management, 2004, Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management, Anesthesiology, 100, 1573, 10.1097/00000542-200406000-00033 Strassels, 2002, Postoperative analgesia: Economics, resource use, and patient satisfaction in an urban teaching hospital, Anesth Analg, 94, 130, 10.1213/00000539-200201000-00025 Pasternak, 2005, Molecular biology of opioid analgesia, J Pain Symptom Manage, 29, S2, 10.1016/j.jpainsymman.2005.01.011 Stamer, 2005, Genetics and variability in opioid response, Eur J Pain, 9, 101, 10.1016/j.ejpain.2004.05.008 Sinatra, 1988, Oxymorphone revisited, Semin Anesth, 7, 208 Gimbel, 2004, The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain, Anesth Analg, 99, 1472, 10.1213/01.ANE.0000132548.91622.B3 Matsumoto, 2005, Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial, Pain Med, 6, 357, 10.1111/j.1526-4637.2005.00057.x Katz, 2007, A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain, Curr Med Res Opin, 23, 117, 10.1185/030079906X162692 Hale, 2007, Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study, J Pain, 8, 175, 10.1016/j.jpain.2006.09.011 Kivitz, 2006, A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee, Clin Ther, 28, 352, 10.1016/j.clinthera.2006.03.008 Adams, 2005, Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets, Drugs R D, 6, 91, 10.2165/00126839-200506020-00004 Rosner, 2000 Johnson, 1997, Bromfenac sodium, acetaminophen/oxycodone, ibuprofen, and placebo for relief of postoperative pain, Clin Ther, 19, 507, 10.1016/S0149-2918(97)80135-X Romsing, 2005, Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: A systematic review, Acta Anaesthesiol Scand, 49, 133, 10.1111/j.1399-6576.2005.00614.x Adams, 2005, Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways, J Clin Pharmacol, 45, 337, 10.1177/0091270004271969 Lalovic, 2004, Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes, Drug Metab Dispos, 32, 447, 10.1124/dmd.32.4.447